Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 3, 1996, Pages 301-306

  Shah, Syed M ^a   Shapshak, Paul ^a   Rivers, James E ^a   Stewart, Renée V ^a   Weatherby, Norman L ^a   Xin, Ke Qin ^a,d   Bryan Page, J ^a,b   Chitwood, Dale D ^a   Mash, Deborah C ^a   Vlahov, David ^c   McCoy, Clyde B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Blood; Cooker; Cotton; HIV 1; IDU behavior; Injection apparatus; Injection drug user (IDU); Injection equipment; Needle; Paraphernalia; Shooting gallery; Syringe; Wash water

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; ARTICLE; DISEASE TRANSMISSION; DNA DETERMINATION; DNA STRUCTURE; DRUG USE; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; SOUTHERN BLOTTING;

EID: 1842614378     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199603010-00010     Document Type: Article

References (35)

1. McCoy CB, Khoury E. Drug use and risk of AIDS. Am Behav Sci 1990;33:419-31.
2. Chitwood DD, McCoy CB, Inciardi JA, et al. HIV seropositivity of needles from shooting galleries in South Florida. Am J Public Health 1990;80:150-2.
3. Page JB, Chitwood DD, Kane PC, McBride DC. Intravenous drug use and HIV infection in Miami. Med Anthropol Q 1990;4:56-71.
4. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994;271:115-20.
5. McCoy CB, Shapshak P, Metsch LR, et al. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. Arch Immunol Ther Exp 1995 (in press).
6. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS 1993;7:1653-60.
7. Inciardi JA, Page JB, McBride DC, et al. The risk of exposure to HIV-contaminated needles in shooting galleries. In: Inciardi JA, McElrath K, eds. The american drug scene. Los Angeles: Roxbury, 1994;277-83.
8. Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR. HIV infection in heterosexual intravenous drug abusers in San Francisco. Am J Public Health 1987;77:169-72.
9. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with HIV among intravenous drug abusers in New York City. AIDS 1987;1:39-44.
10. Schoenbaum EE, Selwyn PA, Feiner CA, et al. Prevalence and risk factors associated with HTLV-III/LAV antibodies among intravenous drug abusers in a methadone program in New York City. Paper presented at the Second International Conference on AIDS, Paris, June 1986.
11. Samuels JF, Vlahov D, Anthony JC, Solomon L, Celentano DD. The practice of "frontloading" among intravenous drug users: association with antibody. AIDS 1991;5:343.
12. Newmeyer JA. Why bleach? Fighting AIDS contagion among intravenous drug users: the San Francisco experience. J Psychoactive Drugs 1988;20:159-63.
13. Shapshak P, McCoy CB, Shah SM, et al. Preliminary laboratory studies on inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J AIDS 1994;7:754-9.
14. Lurie P. The University of California needle exchange program evaluation project: methods, conclusions, and recommendations. In: Proceedings, workshop on needle exchange and bleach distribution programs, National Council Institute of Medicine. Washington, DC: National Academy Press, 1994:7-23.
15. Vlahov D, Brookmeyer RS. Editorial: the evaluation of needle exchange programs. Am J Public Health 1995;84:1889- 91.
16. Oliver KJ, Friedman SR, Maynard H, Magnuson LJ, Des Jarlais DC. Impact of needle exchange program on potentially infectious syringes in public places. J AIDS 1992;5: 534-5.
17. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV- infected needles returned to New Haven's needle exchange program: client shift or needle exchange? Am J Public Health 1995;84:1991-4.
18. Koester SK, Hoffer L. "Indirect sharing": additional HIV risks associated with drug injection. AIDS Public Policy J 1994;9:100-5.
19. Wodak A, Dolan K, Imrie AA, et al. Antibodies to the HIV in needles and syringes used by intravenous drug abusers. Med J Aust 1987;147:275-6.
20. McCoy CB, Shapshak P, Shah SM, et al. HIV-1 prevention: interdisciplinary studies and reviews on efficacy of bleach and compliance to bleach prevention protocols. In: Proceedings, workshop on needle exchange and bleach distribution programs, National Research Council Institute of Medicine. Washington, DC: National Academy Press, 1995:225-83.
21. Heimer R, Myers SS, Cadman EC, Kaplan EH. Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users. J Infect Dis 1992;165:781-2.
22. Vlahov D, Polk BF. Perspectives on infection with HIV-1 among intravenous drug users. Psychopharmacol Bull 1988; 24:325-9.
23. McCoy CB, Rivers JE, McCoy HV, et al. Compliance to bleach disinfection protocols among injecting drug users in Miami. J AIDS 1994;7:773-6.
24. Sambrook J, Maniatis T, Fritsch EF. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
25. Saksena NK, Dwyer D, Barré-Sinoussi F. A "sentinel" technique for monitoring viral aerosol contamination. J Infect Dis 1991;164:1021-2.
26. Ou CY, Mitchell SW, Krebs J, et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral mononuclear cells. Science 1987;239:295-7.
27. 33p-labeled probes to detect human immunodeficiency virus type-1 using polymerase chain reaction. NEN Biotech Updates 1994;9:10-11.
28. Myers G, Berzofsky JA, Korber B, Smith RF, Pavlakis GN. In: Human retroviruses and AIDS. Los Alamos, NM: Department of Theoretical Biology and Biophysics, Los Alamos National Laboratory, 1994.
29. Xin KQ, Shapshak P, Kawamoto S, Nagano I, McCoy CB, Okuda K. Highly divergent env sequences of HIV-1 B subtype with two novel V3 loop motifs detected in an AIDS patient in Miami, Florida. AIDS Res Hum Retroviruses 1995;11:1139-41.
30. Shapshak P, Nagano I, Xin KQ, et al. HIV-1 heterogeneity and cytokines: neuropathogenesis. In: Sharp B, Eisenstein T, Madden J, Friedman H, eds. The brain immune axis and substance abuse. 1995:225-36.
31. Merigan TC, Clark G, Katzenstein D, Holodny M. Correlation between HIV load, stage of disease and dideoxy drug administration using quantitative RNA and DNA PCR and viremia measurements. In: Andrieu J-M, Libby J, eds. Viral quantitation in HIV infection. Paris, Eurotext, 1991: 147-52.
32. Myers SS, Heimer R, Liu D, Henrard D. HIV DNA and antibodies in syringes from IDUs: a comparison of detection techniques. AIDS 1993;7:925-31.
33. Rouzioux C, Burgard M, Blanche S, Mayaux MJ, Koutznetzoff A, Griscelli C, and the HIV infection in Newborns French Collaborative Study Group. Quantitative PCR for the diagnosis of HIV-1 infection in newborns to seropositive mothers. In: Andrieu JM, Libby J, eds. Viral quantitation in HIV infection. Paris: Eurotext, 1991:187-91.
34. Candotti D, Jung M, Kerouedan D, et al. Genetic variability affects the detection of HIV by PCR. AIDS 1991;5: 1003-7.
35. Schnittman SM, Greenhouse JJ, Lane HC, Pierce PF, Fauci AS. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. AIDS Res Hum Retroviruses 1991;7: 361-7.